The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Order BPC 157 (20mg) Buy Research Peptides Medica Depot RFK Jr. and the Perils of Peptides Washington Monthly FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica